Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brijesh Kumar Verma

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Neuro-Oncology|August 18, 2020
Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in gliomaBrijesh Kumar Verma, Paturu Kondaiah
Scientific Reports|September 30, 2025
Mitigating Chloramphenicol induced liver toxicity by exploring the therapeutic potential of Astaxanthin and QuercetinBrijesh Kumar Verma, Hiren M Patel, Debashis Banerjee
Chemical Research in Toxicology|May 7, 2026
Drug-Induced Liver Injury: Mitochondrial Mechanisms, Biomarkers, and Emerging Therapeutic StrategiesBrijesh Kumar Verma, Drashti Bhalgama, Pooja Thakur, et al.
Bioengineering (Basel, Switzerland)|September 28, 2023
Substrate Stiffness Modulates TGF-β Activation and ECM-Associated Gene Expression in FibroblastsBrijesh Kumar Verma, Aritra Chatterjee, Paturu Kondaiah, et al.
Journal of Nanobiotechnology|December 12, 2018
An ultra-stable redox-controlled self-assembling polypeptide nanotube for targeted imaging and therapy in cancerGitanjali Asampille, Brijesh Kumar Verma, Monalisa Swain, et al.
Journal of Neuro-Oncology|January 3, 2021
Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrenceVidya P Nimbalkar, Banavathy S Kruthika, Palavalasa Sravya, et al.
Mitochondrion|October 12, 2020
Low mitochondrial DNA copy number is associated with poor prognosis and treatment resistance in glioblastomaPalavalasa Sravya, Vidya Prasad Nimbalkar, Nandaki Nag Kanuri, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisAbhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Nature Communications|August 29, 2023
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistanceReyaz Ur Rasool, Caitlin M O'Connor, Chandan Kanta Das, et al.
Nature Genetics|September 9, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisAbhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Neuro-Oncology|August 18, 2020
Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in gliomaBrijesh Kumar Verma, Paturu Kondaiah
Scientific Reports|September 30, 2025
Mitigating Chloramphenicol induced liver toxicity by exploring the therapeutic potential of Astaxanthin and QuercetinBrijesh Kumar Verma, Hiren M Patel, Debashis Banerjee
Chemical Research in Toxicology|May 7, 2026
Drug-Induced Liver Injury: Mitochondrial Mechanisms, Biomarkers, and Emerging Therapeutic StrategiesBrijesh Kumar Verma, Drashti Bhalgama, Pooja Thakur, et al.
Bioengineering (Basel, Switzerland)|September 28, 2023
Substrate Stiffness Modulates TGF-β Activation and ECM-Associated Gene Expression in FibroblastsBrijesh Kumar Verma, Aritra Chatterjee, Paturu Kondaiah, et al.
Journal of Nanobiotechnology|December 12, 2018
An ultra-stable redox-controlled self-assembling polypeptide nanotube for targeted imaging and therapy in cancerGitanjali Asampille, Brijesh Kumar Verma, Monalisa Swain, et al.
Journal of Neuro-Oncology|January 3, 2021
Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrenceVidya P Nimbalkar, Banavathy S Kruthika, Palavalasa Sravya, et al.
Mitochondrion|October 12, 2020
Low mitochondrial DNA copy number is associated with poor prognosis and treatment resistance in glioblastomaPalavalasa Sravya, Vidya Prasad Nimbalkar, Nandaki Nag Kanuri, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisAbhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Nature Communications|August 29, 2023
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistanceReyaz Ur Rasool, Caitlin M O'Connor, Chandan Kanta Das, et al.
Nature Genetics|September 9, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisAbhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Pageof 1